Ann: Trading Halt, page-84

I am aware of the RespireRX study for Sleep Apnea also w/ dronabinol.

Of course IHL's Med Board is insane, never seen anything like it in a 50M MC company.

By far the most qualified and specific in picking literal specialists to join the board with incentives at the top of their particular field, in line with Dr Sud's no 'one size fits all' oils and our strategy of targeting specific problems and their markets.
Especially for a, as I reiterate 50M MC company. Ridiculous caliber for this value.

Still, perhaps for the other trials it is unreasonable to say that they are not binary outcomes.
Market is fickle as well, doing well in a trial is not enough, performing to what the market defines as success is.

Nevertheless, IHL still positioned after BOTs catastrophe as undoubtedly the best opportunity for MedCann Biotech in the ASX.
50M MC. Peanuts.